Stop Gambling in the Stock Market. Be an intelligent and confident investor.
See what the professionals see with financial analytics, charts and valuation models.
Fundamental Analysis and Stock Valuation Simplified. Learn more.

Glenmark Pharmaceuticals Ltd. | GLENMARK | NSE - Pharmaceuticals


Performance Trend  |  Valuation  |  Growth  |  Insiders  |  Summary
Balance Sheet  |  Income Statement  |  Cash Flow  |  Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated.

Upgrade Membership to see 10 year accruate financial statements.

  
2015
2016
2017
2018
2019
Net Income
Net Income
5,943
10,440
14,914
11,193
13,006
Cash flow Operating Act...
Cash flow Operating Activities
4,8173,4486,57416,48113,242
Investments in PPE
Investments in PPE
-5,443-8,903-7,485-10,446-12,372
Cash flow Investing Act...
Net cash used for Investment Activities
-5,400-8,802-7,123-10,133-6,990
Cash flow Financing Act...
Net cash provided by Financing Activities
1,9926,9865,432-4,685-7,387
Cash at beginning of period
Cash at beginning of period
7,9487,6378,57110,56412,334
Cash at end of period
Cash at end of period
7,6378,57110,56412,3349,363
Free Cash Flow
Free Cash Flow
-626
-5,454
-911
6,034
870